BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2014 6:47:00 PM | Browse: 1287 | Download: 1134
 |
Received |
|
2013-12-31 14:38 |
 |
Peer-Review Started |
|
2013-12-31 20:31 |
 |
To Make the First Decision |
|
2014-02-13 16:09 |
 |
Return for Revision |
|
2014-02-19 22:37 |
 |
Revised |
|
2014-03-04 06:57 |
 |
Second Decision |
|
2014-06-11 12:26 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-06-11 12:34 |
 |
Articles in Press |
|
2014-06-11 13:11 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-08-28 14:00 |
 |
Publish the Manuscript Online |
|
2014-09-17 14:32 |
Category |
Pathology |
Manuscript Type |
Minireviews |
Article Title |
Management of renal artery stenosis: What does the experimental evidence tell us?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Mohammed Al-Suraih and Joseph Peter Grande |
Funding Agency and Grant Number |
|
Corresponding Author |
Joseph Peter Grande, MD, PhD, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905,
United States. grande.joseph@mayo.edu
|
Key Words |
Renovascular hypertension; CCL2; CCR2; Kidney; Inflammation; Atrophy |
Core Tip |
Renovascular hypertension is a common public health problem, particularly in older patients with underlying atherosclerotic vascular disease. Recent studies have shown that restoration of blood flow in these patients fails to improve renal function or survival. Recent studies to define basic mechanisms underlying the development of chronic renal disease in renin angiotensin system (RAS) have shown that pro-inflammatory pathways may play a critical role in this process. Therapeutic approaches that target inflammatory pathways may provide the basis for novel and more effective treatments for patients with RAS. |
Publish Date |
2014-09-17 14:32 |
Citation |
Al-Suraih M, Grande JP. Management of renal artery stenosis: What does the experimental evidence tell us? World J Cardiol 2014; 6(8): 855-860 |
URL |
http://www.wjgnet.com/1949-8462/full/v6/i8/855.htm |
DOI |
http://dx.doi.org/10.4330/wjc.v6.i8.855 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345